Clinical trial
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment…
NCT00385593 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00385593 |
|---|---|
| Title | Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults |
| Official title | A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 Micrograms, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-week, Randomised, Open-label, Parallel-group, Multicentre Study. Study SPAIN |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma, Bronchial |
| Intervention type | Drug |
| Interventions | Symbicort (budesonide/formoterol) Turbuhaler, Conventional treatment |
| Enrollment | 654 |
| Start date | Sep 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Oct 9, 2006 |
| Last update posted | Dec 16, 2010 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: